Pulse Biosciences, Inc. (PLSE)
NASDAQ · Healthcare
Pulse Biosciences, Inc. Total Liabilities 2020–2025
Pulse Biosciences, Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Pulse Biosciences, Inc. total liabilities for the quarter ending December 31, 2025 were 13.9M, a 21.11% decrease year-over-year.
- Pulse Biosciences, Inc. total liabilities for 2025 were 13.9M, a 21.11% decrease from 2024.
- Pulse Biosciences, Inc. total liabilities for 2024 were 17.6M, a 18.95% increase from 2023.
- Pulse Biosciences, Inc. total liabilities for 2023 were 14.8M, a 81.54% decrease from 2022.
- Pulse Biosciences, Inc. total liabilities for 2022 were 80.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Pulse Biosciences, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $14 |
| 2024 | $18 |
| 2023 | $15 |
| 2022 | $80 |
| 2021 | $15 |
| 2020 | $18 |
| Pulse Biosciences, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $14 |
| 2024-12-31 | $18 |
| 2023-12-31 | $15 |
| 2022-12-31 | $80 |
| 2021-12-31 | $15 |
| 2020-12-31 | $18 |
Pulse Biosciences, Inc. Total Liabilities — FAQ
Pulse Biosciences, Inc. (PLSE) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLSE's total liabilities history?
The chart and table above show Pulse Biosciences, Inc.'s total liabilities by year and by quarter, including the growth rate.